High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy

References

• Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer-mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455–65. doi:10.1038/nrendo.2014.94
   PubMed Web of Science ®Google Scholar
• Reggiani F, Bertolini F. Roles of obesity in the development and progression of breast cancer. Discov Med. 2017;24(133):183–90.
   PubMed Web of Science ®Google Scholar
• Jiralerspong S, Goodwin PJ. Obesity and breast cancer prognosis: Evidence, challenges, and opportunities. J Clin Oncol. 2016;34(35):4203–16. doi:10.1200/jco.2016.68.4480
   PubMed Web of Science ®Google Scholar
• Argolo DF, Hudis CA, Iyengar NM. The impact of obesity on breast cancer. Curr Oncol Rep. 2018;20(6):47. doi:10.1007/s11912-018-0688-8
   PubMed Web of Science ®Google Scholar
• Garcia-Estevez L, Moreno-Bueno G. Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res. 2019;21(1):35. doi:10.1186/s13058-019-1124-1
   PubMed Web of Science ®Google Scholar
• Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15(3):139–154. doi:10.1038/s41574-018-0126-x
   PubMed Web of Science ®Google Scholar
• Orecchioni S, Reggiani F, Talarico G, Bertolini F. Mechanisms of obesity in the development of breast cancer. Discov Med. 2015;20(109):121–8.
   PubMed Web of Science ®Google Scholar
• Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23(2):83–9. doi:10.1016/j.tem.2011.10.003
   PubMed Web of Science ®Google Scholar
• Bandera EV, John EM. Obesity, body composition, and breast cancer: An evolving science. JAMA Oncol. 2018;4(6):804–805. doi:10.1001/jamaoncol.2018.0125
   PubMed Web of Science ®Google Scholar
• Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134. doi:10.1136/bmj.39367.495995.AE
   PubMed Web of Science ®Google Scholar
• Gourd E. Sarcopenia and adiposity linked to overall survival. Lancet Oncol. 2018;19(5):e239. doi:10.1016/S1470-2045(18)30284-5
   PubMed Web of Science ®Google Scholar
• Sparreboom A, Wolff AC, Mathijssen RHJ, Chatelut E, Rowinsky EK, Verweij J, Baker SD. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. JCO. 2007;25(30):4707–4713. doi:10.1200/JCO.2007.11.2938
   PubMed Web of Science ®Google Scholar
• Wong AL, Seng KY, Ong EM, Wang LZ, Oscar H, Cordero MT, Copones R, Fan L, Tan SH, Goh BC, et al. Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients. Breast Cancer Res Treat. 2014;144(1):143–52.: doi:10.1007/s10549-014-2843-8
   PubMed Web of Science ®Google Scholar
• Kang C, LeRoith D, Gallagher EJ. Diabetes, obesity, and breast cancer. Endocrinology. 2018;159(11):3801–3812. doi:10.1210/en.2018-00574
   PubMed Web of Science ®Google Scholar
• Nakao YM, Miyawaki T, Yasuno S, Nakao K, Tanaka S, Ida M, Hirata M, Kasahara M, Hosoda K, Ueshima K, et al. Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study). Proc Jpn Acad, Ser B. 2012;88(8):454–61. doi:10.2183/pjab.88.454
   PubMed Web of Science ®Google Scholar
• Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obes Rev. 2021;22(1):e13088. doi:10.1111/obr.13088
   PubMed Web of Science ®Google Scholar
• Aparecida Silveira E, Vaseghi G, de Carvalho Santos AS, Kliemann N, Masoudkabir F, Noll M, Mohammadifard N, Sarrafzadegan N, de Oliveira C. Visceral obesity and its shared role in cancer and cardiovascular disease: A scoping review of the pathophysiology and pharmacological treatments. IJMS. 2020;21(23):9042. doi:10.3390/ijms21239042
   Web of Science ®Google Scholar
• Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr. 1998;68:899–917. doi:10.1093/ajcn/68.4.899
   PubMed Web of Science ®Google Scholar
• Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015;34(3):335–40.: doi:10.1016/j.clnu.2015.03.001
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: A review. JAMA. 2019;321(3):288–300. doi:10.1001/jama.2018.19323
   PubMed Web of Science ®Google Scholar
• Rubin R. Postmenopausal women with a “normal” BMI might be overweight or even obese. JAMA. 2018;319(12):1185–1187. doi:10.1001/jama.2018.0423
   PubMed Web of Science ®Google Scholar
• Iwase T, Sangai T, Nagashima T, Sakakibara M, Sakakibara J, Hayama S, Ishigami E, Masuda T, Miyazaki M. Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Med. 2016;5(1):41–8. doi:10.1002/cam4.571
   PubMed Web of Science ®Google Scholar
• Iwase T, Sangai T, Fujimoto H, Sawabe Y, Matsushita K, Nagashima K, Sato Y, Nakagawa A, Masuda T, Nagashima T, et al. Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer. Breast Cancer Res Treat. 2020;179(2):435–443. doi:10.1007/s10549-019-05467-7
   PubMed Web of Science ®Google Scholar
• Prado CMM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, Mackey JR, Koski S, Pituskin E, Sawyer MB, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15(8):2920–6. doi:10.1158/1078-0432.ccr-08-2242
   PubMed Web of Science ®Google Scholar
• Shachar SS, Deal AM, Weinberg M, Nyrop KA, Williams GR, Nishijima TF, Benbow JM, Muss HB. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving Taxane-based chemotherapy. Clin Cancer Res. 2017;23(3):658–665. doi:10.1158/1078-0432.CCR-16-0940
   PubMed Web of Science ®Google Scholar
• Cespedes Feliciano EM, Chen WY, Lee V, Albers KB, Prado CM, Alexeeff S, Xiao J, Shachar SS, Caan BJ. Body composition, adherence to anthracycline and taxane-based chemotherapy, and survival after nonmetastatic breast cancer. JAMA Oncol. 2020;6(2):264–270. doi:10.1001/jamaoncol.2019.4668
   PubMed Web of Science ®Google Scholar
• Hunter GR, Gower BA, Kane BL. Age related shift in visceral fat. Int J Body Compos Res. 2010;8(3):103–108.
   PubMedGoogle Scholar
• Zimta A-A, Tigu AB, Muntean M, Cenariu D, Slaby O, et al. Molecular links between central obesity and breast cancer. Int J Mol Sci. 2019;20:5364. doi:10.3390/ijms20215364
   PubMed Web of Science ®Google Scholar
• Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr. 2011;3:12–12. doi:10.1186/1758-5996-3-12
   PubMed Web of Science ®Google Scholar
• Ritter A, Friemel A, Fornoff F, Adjan M, Solbach C, Yuan J, Louwen F. Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells. Oncotarget. 2015;6(33):34475–34493. doi:10.18632/oncotarget.5922
   PubMedGoogle Scholar
• Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697–738. doi:10.1210/edrv.21.6.0415
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60. doi:10.1210/jc.2011-0615
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring. 2013;21(9):E439–47. doi:10.1002/oby.20135
   PubMed Web of Science ®Google Scholar
• Himbert C, Delphan M, Scherer D, Bowers LW, Hursting S, Ulrich CM. Signals from the adipose microenvironment and the obesity-cancer link-A systematic review. Cancer Prev Res (Phila). 2017;10(9):494–506. doi:10.1158/1940-6207.capr-16-0322
   PubMed Web of Science ®Google Scholar
• Cartier A, Lemieux I, Alméras N, Tremblay A, Bergeron J, Després J-P, Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab. 2008;93(5):1931–8. doi:10.1210/jc.2007-2191
   PubMed Web of Science ®Google Scholar
• Zelenko Z, Gallagher EJ, Antoniou IM, Sachdev D, Nayak A, Yee D, LeRoith D. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice. Endocr Relat Cancer. 2016;23(9):747–58. doi:10.1530/erc-16-0142
   PubMed Web of Science ®Google Scholar
• Nelson ER. The significance of cholesterol and its metabolite, 27-hydroxycholesterol in breast cancer. Mol Cell Endocrinol. 2018;466:73–80. doi:10.1016/j.mce.2017.09.021
   PubMed Web of Science ®Google Scholar
• Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Goodwin PJ. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat. 2005;94(2):135–44. doi:10.1007/s10549-005-6654-9
   PubMed Web of Science ®Google Scholar
• Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, Carver NJ, Pillai RV, Sullivan PM, Sondhi V, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342(6162):1094–1098. doi:10.1126/science.1241908
   PubMed Web of Science ®Google Scholar
• Ghigliotti G, Barisione C, Garibaldi S, Fabbi P, Brunelli C, Spallarossa P, Altieri P, Rosa G, Spinella G, Palombo D, et al. Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation. 2014;37(4):1337–1353. doi:10.1007/s10753-014-9914-1
   PubMed Web of Science ®Google Scholar
• Li C, Spallanzani RG, Mathis D. Visceral adipose tissue Tregs and the cells that nurture them. Immunol Rev. 2020;295(1):114–125. doi:10.1111/imr.12850
   PubMed Web of Science ®Google Scholar
• Pudkasam S, Tangalakis K, Chinlumprasert N, Apostolopoulos V, Stojanovska L, Breast cancer and exercise: The role of adiposity and immune markers. Maturitas. 2017;105:16–22. doi:10.1016/j.maturitas.2017.04.022
   PubMed Web of Science ®Google Scholar